Quarterly report · Q1
2689.TEDINET S100PJIX
Period2022-07-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.3bn | 2022-07-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥108.0bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥25.0bn | 2021-07-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥403m | 2022-07-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥249m | 2021-07-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥404m | 2022-07-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥257m | 2021-07-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥402m | 2022-07-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥242m | 2021-07-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥251m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥175m | 2021-07-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥251m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥175m | 2021-07-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥38.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥40.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥38.3bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥29.5bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥30.9bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥9.0bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥9.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.2bn | at 2022-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥41.84 | 2022-07-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥252.8 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.81 | 2021-07-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 23.3% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.8% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.9% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | −¥394m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-09-30 | −¥394m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥38m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥616m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥616m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥23,000 |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥47m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥24.8bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥24.5bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥363m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥347m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥32m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥47m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2022-09-30 | ¥26.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2022-09-30 | ¥26.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥394m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2022-09-30 | ¥441m |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2021-09-30 | −¥342m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2021-09-30 | −¥342m |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-09-30 | −¥48m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥582m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥582m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥14,000 |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥39m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥23.6bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥23.3bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥311m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥231m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥31m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥28m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2021-09-30 | ¥25.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2021-09-30 | ¥25.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥342m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2021-09-30 | ¥298m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 354
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |